Diabetes
Conditions
Interventions
Lifestyle behavior improvement support by feedback from the App based on input data.
Sponsors
Mitsubishi Tanabe Pharma Corporation
Habitus Care Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged over 20 years or older at the time of informed consent (both genders) 2) Patients with documented consent to participate in the study 3) Patients diagnosed with type 2 diabetes mellitus 4) Patients taking hypoglycemic drugs 5) Patients with HbA1c >= 6.5 6) Patients with a smartphone
Exclusion criteria
Exclusion criteria: 1) A female subject who wishes to become pregnant, is pregnant, or is breastfeeding 2) Patients diagnosed with type 1 diabetes mellitus 3) Patients with a diagnosis of secondary diabetes mellitus 4) Patients with physician-determined advanced complications 5) Patients scheduled for hospitalization or surgery during this study 6) Patients with diseases other than diabetes mellitus who are instructed to restrict exercise 7) Patients who have participated in a clinical study or a post-marketing clinical study of another prescription drug or a medical device within 3 months, who are now participating in such a study, or who plan to participate in such a study during this study 8) Patients who have used a mobile application running on a smartphone terminal for the purpose of managing or assisting diabetes mellitus within the past 3 months 9) Medical institution staff or close relatives involved in this study 10) Other patients judged by the investigator to be inappropriate for inclusion in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight, HbA1c, completion rate, utilization of App, improvement of blood test value | — |
Countries
Japan
Contacts
Public ContactKoji Tokutomi
Mitsubishi Tanabe Pharma Corporation Digital Transformation Department
Outcome results
None listed